longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Tianshan Bio

300313

14.995.72% ( -0.91 )
Delay Closed: Sep 9, 15:00:00
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -237.07, below the reasonable range, cheaper than 97.76% of the time in the past 5 years, and the industry ranks 79/85, the industry Median 11.75.

-237.07xP/E
¥14.99Stock price
¥-0.06Earnings per share
-237.07xP/E
Stock price¥14.99Earnings per share¥-0.06

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-60.20x
Typical range
-108.21x–-47.84x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.75x
03978117156

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.75x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
603392SHWantai Biological
-92.74x22.02%¥35.48B
688180SHJunshi Biosciences
-75.32x92.53%¥33.20B
300122SZZHIFEI-BIOL
-2.12x91.71%¥31.60B
688192SHDizal Pharmaceutical
-42.77x255.85%¥25.54B
688520SHSinocelltech
-17.84x171.21%¥16.00B
300676SZBGI Genomics
-26.79x118.23%¥15.41B
688765SHHEALTHGEN BIOTECH
-97.42x--¥13.46B
688319SHOlymvax Biopharmaceuticals
-496.35x227.87%¥11.82B
688062SHMabwell
-12.37x37.63%¥11.62B
300204SZStaidson BioPharm
-125.26x--¥11.26B
688382SHInventisBio
-32.78x5.45%¥10.97B
688105SHVazyme
-1,201.76x770.82%¥10.55B
688806SHTrinomab Pharmaceutical
-19.55x--¥9.98B
688759SHBeBetter Med
-54.51x12.50%¥9.68B
688443SHGenrix Bio
-14.71x32.19%¥8.28B
002030SZDAJY
-11.31x--¥7.72B
300294SZBOYA BIOLOGY
-121.11x281.82%¥7.44B
688177SHBIO-THERA
-15.40x2.47%¥7.07B
688276SHBCHT
-27.62x66.67%¥6.66B
688488SHAidea Pharma
-1,096.08x--¥6.35B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.